We conduct personalized diagnoses using complementary platforms such as Multiplex Blot, POCT, and m-Health. These platforms have been commercialized based on the convergence of bio, nano, and IT technologies. Over the past 10 years, our goal has been to enhance the mobile care system, enabling disease prediction and prevention, diagnosis, customized prescription, and post-treatment monitoring. Our vision is to become a global leader in in vitro diagnostic total platforms, providing accessible solutions for everyone.